This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by McDonald, T J. Articles by Nijland, M. J. Search for Related Content PubMed PubMed Citation Articles by McDonald, T J. Articles by Franko, K. L. Articles by Brown, J. M. Articles by Jenkins, S. L. Articles by Nathanielsz, P. W. Articles by Nijland, M. J. Social Bookmarking                         What's this?

Betamethasone in the Last Week of Pregnancy Causes Fetal Growth Rtardation but Not Adult Hypertension in Rats

Laboratory for Pregnancy and Newborn Research, Department of Obstetrics and Gynecology, New York University School of Medicine, New York, New York; tmcdonal{at}sfbr.org

K. L. Franko

J. M. Brown

S. L. Jenkins, MS

P. W. Nathanielsz, MD, PhD

M. J. Nijland, PhD

Laboratory for Pregnancy and Newborn Research, Department of Obstetrics and Gynecology, New York University School of Medicine, New York, New York

Background: We tested the hypotheses that (1) maternal betamethasone (ßM) treatment over the range of clinical doses for prevention of prematurity-related pathologies from day 15 to 21 of rat gestation would produce growth retardation, and (2) the lowest ßM dose to produce growth retardation would result in hypertension in adult offspring.

Methods: In experiment 1, pregnant Sprague-Dawley rats were administered ßM (0, 50, 100, 200, 400, or 600 µg/kg per day, subcutaneously) on days 15-21 of pregnancy and necropsied on day 21.5, with fetal lung and placental weights recorded. In experiment 2, two more groups of rats (0 or 100 µg/kg per day, subcutaneously) were allowed to deliver, and offspring were instrumented at 100 ± 4 days of postnatal life with indwelling left carotid arterial catheters. After 48 hours of recovery, blood pressure was recorded continuously for 24 hours.

Results: In experiment 1, all newborn rats treated with ßM, and their placentas, except those receiving 50 µg/kg per day, were growth retarded in comparison with controls (P < .05). All treated lungs were smaller than those of controls (P < .05). In experiment 2, no differences were found in the mean arterial blood pressure of adult offspring given the lowest effective dose of ßM (100 µg/kg per day) compared with controls (114.2 ± 5.3 mmHg versus 114.6 ± 3.4 mmHg, respectively).

Conclusion: These data suggest that glucocorticoids given in the last week of rat pregnancy in the lowest human clinical dose do not cause hypertension and somatic growth retardation. However, the presence of lung growth restriction at this dose argues for more studies on the efficacy of even lower concentrations for their ability to improve lung and other organ and tissue function while avoiding unwanted side effects.

Key Words: Blood pressure • body weight • glucocorticoids • pregnancy • stress

Journal of the Society for Gynecologic Investigation, Vol. 10, No. 8, 469-473 (2003)
DOI: 10.1016/S1071-55760300151-5


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?